Furthermore, it is tempting to speculate that circulating PlGF/sFlt1circ and tissue-based PlGF expression may reflect genetic subtypes of PDAC with enhanced capacities of tumor-nerve crosstalk allowing patients’ allocation to modified treatment algorithms. Here, PGF is linked to neoplasm.